Incidence of Growth Hormone Deficiency in Pediatric-Onset Langerhans Cell Histiocytosis: Efficacy and Safety of Growth Hormone Treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 2, 2004, Pages 604-609

  Donadieu, Jean ^a   Rolon, Maria Alejandra ^b   Pion, Isabelle ^c   Thomas, Caroline ^d   Doz, François ^e   Barkaoui, Mohamed ^f   Robert, Alain ^g   Deville, Anne ^h   Mazingue, Françoise ⁱ   David, Michel ^j   Brauner, Raja ^k   Cabrol, Sylvie ^a   Garel, Catherine ^l   Polak, Michel ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Laboratoire Pharmacia   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e INSTITUT CURIE   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g CHU PURPAN   (France)

^h INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j CENTRE HOSPITALIER LYON SUD   (France)

^k SAINT JOSEPH HOSPITAL   (France)

^l HÔPITAL ROBERT DEBRÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DIABETES INSIPIDUS; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GROWTH ACCELERATION; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HISTIOCYTOSIS; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LANGERHANS CELL; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH; HISTIOCYTOSIS, LANGERHANS-CELL; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY DISEASES; PITUITARY GLAND, ANTERIOR; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 10744224534     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030907     Document Type: Article

References (25)

1. Braunstein GD, Kohler PO 1972 Pituitary function in Hand Shuller Christian disease. N Engl J Med 286:1225-1229
2. Braunstein GD, Raiti S, Hansen JW, Kohler PO 1975 Response of growth retarded patients with Hand-Schuller-Christian disease to growth hormone therapy. N Engl J Med 292:332-333
3. Braunstein GD, Kolher PO 1981 Endocrine manifestations of histiocytosis. Am J Pediatr Hematol Oncol 3:67-75
4. Dean HJ, Bishop A, Winter JS 1986 Growth hormone deficiency in patients with histiocytosis X. J Pediatr 109:615-618
5. Nanduri VR, Bareille P, Pritchard J, Stanhope R 2000 Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 53:509-515
6. Howell SJ, Wilton P, Shalet SM 1998 Growth hormone replacement in patients with Langerhan's cell histiocytosis. Arch Dis Child 78:469-473
7. Van den Hoek AC, Karstnes A, Egeler RM, Hahlen K 1995 Growth of the children with Langerhans cell histiocytosis. Eur J Pediatr 154:822-825
8. Histiocyte Society Writing Group 1987 Histiocytosis syndrome in children. Lancet 15:208-209
9. The French Langerhans' Cell Histiocytosis Study Group 1996 A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75:17-24
10. Barthez MA, Araujo E, Donadieu J 2000 Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 15:150-156
11. Grois NG, Favara BE, Mostbeck GH, Prayer D 1998 Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:287-305
12. Leger J, Velasquez A, Garel C, Hassan M, Czernichow P 1999 Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 84:1954-1960
13. Maghnie M, Arico M, Villa A, Genovese E, Beluffi G, Severi F 1992 MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis. AJNR Am J Neuroradiol 13:1365-1371
14. Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R 1991 Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 21:247-249
15. Seidel FG, Towbin R, Kaufman RA 1985 Normal pituitary stalk size in children: CT study. Am J Roentgenol 145:1297-1302
16. Jolicoeur P, Pontier J, Pernin MO, Sempe M 1988 A lifetime asymptotic growth curve for human height. Biometrics 44:995-1003
17. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children height at ages 269 years allowing for heights of the parents. Arch Dis Child 45:755-762
18. Dattani MT 2001 Tests in paediatric endocrinology and normal values. In: Brook CGD, Hindmarsh C, eds. Endocrinology. Cambridge, UK: Blackwell Science; 467-490
19. Collet D 1994 Modelling survival data in medical research. London: Chapman and Hall
20. Rozenzweig KE, Arceci RJ, Tarbell NJ 1997 Diabetes insipidus secondary to Langerhans cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol 29:36-40
21. El-Sayed S, Brewin TB 1992 Histiocytosis X: does radiotherapy still have a role? Clin Oncol (R Coll Radiol) 4:27-31
22. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A 1993 Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metab 76:574-579
23. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A 1997 Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 82:418-420
24. Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A 1997 Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 patients of the Kabi Pharmacia International Growth Study. Horm Res 48:62-71
25. Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S 1997 A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group. J Clin Endocrinol Metab 82:452-456